VAERS reports by lot

Merck Pneumococcal lot T022294: VAERS reports

61 VAERS reports list lot T022294 as a Merck Pneumococcal vaccine, received between 2020-10-22 and 2022-04-22. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
61
Reports
0%
Marked serious
0
With a death outcome
15
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction4833%
General / Systemic (non-local)2316%
Musculoskeletal2114%
Allergic / Anaphylactic2014%
Dermatological (non-injection-site)1510%
Cardiac / Cardiovascular86%
Neurological64%
Gastrointestinal32%
Respiratory11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Florida10
Kansas5
North Carolina4
Oregon4
Arkansas3
Pennsylvania3
Michigan3
Missouri2
Ohio2
South Carolina2
Massachusetts2
Maryland2

Reports by month received

2020-104
2020-1115
2020-129
2021-0114
2021-022
2021-031
2021-051
2021-063
2021-071
2021-081
2021-093
2021-103
2022-011
2022-021
2022-042

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.